JAMA Network Home
Sign In
Viewpoint

Rethinking Antifungal Therapy in Seborrheic Dermatitis

JAMA Dermatology 10.1001/jamadermatol.2026.2869

August 19, 2026 at 11:00 AM EDT

Read the full article

This Viewpoint describes growing concerns about antifungal resistance in the treatment of patients with seborrheic dermatitis.

Corresponding Author: John S. Barbieri, MD, MBA, Department of Dermatology, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115 (jbarbieri@bwh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2026.2869?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081926

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks